Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Catalent Inc
(NY:
CTLT
)
59.55
-0.26 (-0.43%)
Streaming Delayed Price
Updated: 12:44 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Catalent Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Catalent, Inc. Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast
October 20, 2021
From
Catalent, Inc.
Via
Business Wire
Chair And CEO Of Catalent Trades $22M In Company Stock
October 06, 2021
John Chiminski, Chair And CEO at Catalent (NYSE:CTLT), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
September 23, 2021
From
Catalent, Inc.
Via
Business Wire
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
September 23, 2021
From
Catalent, Inc.
Via
Business Wire
Where Catalent Stands With Analysts
September 08, 2021
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ...
Via
Benzinga
Catalent's Debt Overview
August 25, 2021
Shares of Catalent (NYSE:CTLT) rose by 23.76% in the past three months. Before having a look at the importance of debt, let us look at how much debt Catalent has. Catalent...
Via
Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
September 07, 2021
From
Catalent, Inc.
Via
Business Wire
Market Rally At Highs, Led By Apple, Growth Stocks: Weekly Review
September 03, 2021
The market rally hit fresh highs this week, with growth leading the way.
Via
Investor's Business Daily
Topics
Bonds
Economy
Stocks
Exposures
Debt Markets
Fossil Fuels
Interest Rates
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
10 Biggest Price Target Changes For Tuesday
August 31, 2021
Morgan Stanley raised Lowe's Companies, Inc. (NYSE:L...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript
August 30, 2021
CTLT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop
August 30, 2021
Toward the end of trading Monday, the Dow traded up 0.02% to 35,462.17 while the NASDAQ rose 1.02% to 15,283.07. The S&P also rose, gaining 0.59% to 4,535.90. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge
August 30, 2021
Midway through trading Monday, the Dow traded up 0.10% to 35,490.10 while the NASDAQ rose 0.85% to 15,258.38. The S&P also rose, gaining 0.59% to 4,536.02. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera
August 30, 2021
Following the market opening Monday, the Dow traded down 0.13% to 35,408.32 while the NASDAQ rose 0.61% to 15,221.76. The S&P also rose, gaining 0.32% to 4,523.75. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal
August 30, 2021
Catalent Inc (NYSE: CTLT) has reported Q4 sales of $1.19 billion, +25% Y/Y as reported, or 22% in constant currency, edging out analysts' average expectation...
Via
Benzinga
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
August 30, 2021
From
Catalent, Inc.
Via
Business Wire
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
August 30, 2021
From
Catalent, Inc.
Via
Business Wire
Highlander Partners Announces the Signing of a Definitive Agreement to Sell Bettera Brands to Catalent
August 30, 2021
From
Highlander Partners
Via
Business Wire
A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs
August 30, 2021
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P and the Nasdaq hit record closing highs in the previous session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
5 Stocks To Watch For August 30, 2021
August 30, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Zoom Video Communications Inc (NASDAQ: ZM) to report quarterly earnings at $1.16 per share on...
Via
Benzinga
Earnings Scheduled For August 30, 2021
August 30, 2021
Companies Reporting Before The Bell Catalent Inc (NYSE: CTLT) is expected to report quarterly earnings at $1.03 per share on revenue of $1.14 billion. Cloudera, Inc. (NYSE: CLDR...
Via
Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
A Look Into Catalent's Price Over Earnings
August 25, 2021
In the current market session, Catalent Inc. (NYSE:CTLT) is trading at $126.21, after a 0.1% drop. However, over the past month, the stock went up by 8.33%, and in...
Via
Benzinga
EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines
August 25, 2021
European Medical Agency (EMA) has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer Inc (NYSE: PFE) - ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.